HAEK:XETRA Haemato AG

EUR 21.40 0.00 0
Icon

Haemato AG (HAEK:XETRA) Stock Analysis and Price Targets

COMMON STOCK | | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 21.40

0.00 (0.00)%

EUR 0.11B

1.79K

N/A

N/A

Icon

HAEK:XETRA

Haemato AG (EUR)
COMMON STOCK | XETRA
EUR 21.40
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.11B

N/A

EUR 21.40

Haemato AG (HAEK:XETRA) Stock Forecast

N/A

Based on the Haemato AG stock forecast from 0 analysts, the average analyst target price for Haemato AG is not available over the next 12 months. Haemato AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Haemato AG is Very Bullish, which is based on 3 positive signals and 0 negative signals. At the last closing, Haemato AG’s stock price was EUR 21.40. Haemato AG’s stock price has changed by +0.00% over the past week, +0.94% over the past month and +14.44% over the last year.

No recent analyst target price found for Haemato AG
No recent average analyst rating found for Haemato AG

Company Overview Haemato AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC p...Read More

https://www.haemato.ag

Lilienthalstrasse 5c, Schönefeld, Germany, 12529

76

December

EUR

Germany

Adjusted Closing Price for Haemato AG (HAEK:XETRA)

Loading...

Unadjusted Closing Price for Haemato AG (HAEK:XETRA)

Loading...

Share Trading Volume for Haemato AG Shares

Loading...

Compare Performance of Haemato AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for HAEK:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Haemato AG (Sector: )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RYSD:XETRA
NatWest Group PLC 0.00 (0.13%) EUR30.45B N/A N/A

ETFs Containing HAEK

Symbol Name HAEK's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Haemato AG (HAEK:XETRA) Stock

Stock Target Advisor's fundamental analysis for Haemato AG's stock is Very Bullish.

HAEK:XETRA stock's dividend yield is 5.61%.

Unfortunately we do not have enough data on HAEK:XETRA's stock to indicate what its average analyst target is.

HAEK:XETRA stock's Price/Earning ratio is 11.57. Based on this HAEK:XETRA may be undervalued for its sector.

The last closing price of HAEK:XETRA's stock was EUR 21.40.

The most recent market capitalization for HAEK:XETRA is EUR 0.11B.

Unfortunately we do not have enough analyst data on HAEK:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Haemato AG's stock.

As per our most recent records Haemato AG has 76 Employees.

Haemato AG's registered address is Lilienthalstrasse 5c, Schönefeld, Germany, 12529. You can get more information about it from Haemato AG's website at https://www.haemato.ag.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...